ConductScience.org, home

Paper32508653

Discovering Anti-Cancer Drugs via Computational Methods.

Cui W and 5 others. Front Pharmacol, 2020. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Discovering Anti-Cancer Drugs via Computational Methods. Papers, record 32508653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32508653

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovering Anti-Cancer Drugs via Computational Methods.
PubMed
Journal
Front Pharmacol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
9.9
iCite
Revised in PubMed
2024-03-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cui WWenqiang
2Aouidate AAdnane
3Wang SShouguo
4Yu QQiuliyang
5Li YYanhua
6Yuan SShuguang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123651482Methods and applications of structure based pharmacophores in drug discovery.Curr Top Med Chem2013https://conductscience.org/library/papers/23651482PubMed
218274745EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.Eur J Nucl Med Mol Imaging2008https://conductscience.org/library/papers/18274745PubMed
330230381Executive functions and health behaviors associated with the leading causes of death in the United States: A systematic review.J Health Psychol2020https://conductscience.org/library/papers/30230381PubMed
431320117Advancing Drug Discovery via Artificial Intelligence.Trends Pharmacol Sci2019https://conductscience.org/library/papers/31320117PubMed
527019343Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations.J Chem Inf Model2016https://conductscience.org/library/papers/27019343PubMed
624591595Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24591595PubMed
731710991In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents.Comput Biol Chem2019https://conductscience.org/library/papers/31710991PubMed
816175177HSP90 and the chaperoning of cancer.Nat Rev Cancer2005https://conductscience.org/library/papers/16175177PubMed
931902900Drug Discovery Researches on Modulators of Lysine-Modifying Enzymes Based on Strategic Chemistry Approaches.Chem Pharm Bull (Tokyo)2020https://conductscience.org/library/papers/31902900PubMed
1017016424Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.Nat Rev Drug Discov2006https://conductscience.org/library/papers/17016424PubMed
1126205061Molecular docking and structure-based drug design strategies.Molecules2015https://conductscience.org/library/papers/26205061PubMed
1216756493Structure and mechanism of the Hsp90 molecular chaperone machinery.Annu Rev Biochem2006https://conductscience.org/library/papers/16756493PubMed
137990113Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.J Med Chem1994https://conductscience.org/library/papers/7990113PubMed
1430209701Ivosidenib: First Global Approval.Drugs2018https://conductscience.org/library/papers/30209701PubMed
1527362234Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.Nature2016https://conductscience.org/library/papers/27362234PubMed
1630155234Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.Chem Sci2018https://conductscience.org/library/papers/30155234PubMed
1716567363GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition.Bioinformatics2006https://conductscience.org/library/papers/16567363PubMed
1829247830Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.J Thorac Oncol2018https://conductscience.org/library/papers/29247830PubMed
1930721452Gilteritinib: First Global Approval.Drugs2019https://conductscience.org/library/papers/30721452PubMed
2031372957Entrectinib: First Global Approval.Drugs2019https://conductscience.org/library/papers/31372957PubMed

See all 120 referencesDownload CSV of references

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
42798927Integrating Machine Learning Approaches and Topological Indices for Prediction of Electronic Properties in Anticancer Drugs.ACS Omega2026https://conductscience.org/library/papers/42798927PubMed
42757169Targeting cancer hallmarks with microbiome-derived bacteriocins and postbiotics: molecular mechanisms and translational opportunities in oncology.Front Oncol2026https://conductscience.org/library/papers/42757169PubMed
42591656Virtual screening identifies specnuezhenide as a potential therapeutic agent for rosacea via KLK5/TLR4/NF-κB pathway inhibition and metabolic modulation.Front Immunol2026https://conductscience.org/library/papers/42591656PubMed
42367280Analysis of the interaction network relationship between drugs using a graph neural network.Front Pharmacol2026https://conductscience.org/library/papers/42367280PubMed
42360583Machine learning-driven prioritization and experimental validation of traditional Chinese medicine-derived STING-inhibitory candidates.Mol Divers2026https://conductscience.org/library/papers/42360583PubMed
42234666In silico characterization of bioactive phytochemicals as antivirals targeting the reovirus σ1 protein for inhibiting σ1-mediated host cell entry.PLoS One2026https://conductscience.org/library/papers/42234666PubMed
42105068Machine Learning-driven Prediction of Cervical Cancer Cell Viability After Treatment With Thymoquinone, Curcumin, and 5-Fluorouracil.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/42105068PubMed
41793680Quinoxaline as Dual Modulators of Apoptotic Regulators Bcl-2 and Bax: A Combined In Vitro and In Silico Anticancer Approach.Asian Pac J Cancer Prev2026https://conductscience.org/library/papers/41793680PubMed
41566300Chemical constituents of Rhazya stricta as potential Aurora kinase A inhibitors for targeting HER2-negative breast cancer: an integrated in-silico and in-vitro study.BMC Complement Med Ther2026https://conductscience.org/library/papers/41566300PubMed
41524971AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era.J Comput Aided Mol Des2026https://conductscience.org/library/papers/41524971PubMed
41471329Synthetic Linear Lipopeptides and Lipopeptoids Induce Apoptosis and Oxidative Stress: In Vitro Cytotoxicity and SAR Evaluation Against Cancer Cell Lines.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471329PubMed
41460364Needle-in-a-haystack approach: rapid screening of PDE1C inhibitors through the combination of machine learning, molecular docking, molecular dynamics simulations and experimental validation.J Comput Aided Mol Des2025https://conductscience.org/library/papers/41460364PubMed
41426052Synthesis and anticancer potential of glycosides.RSC Adv2025https://conductscience.org/library/papers/41426052PubMed
41335181Design, synthesis, characterization, computational analysis, structure-activity relationship, and investigation of the anticancer potential of novel dibromodibenzoazepine-based hybrid structures.Mol Divers2026https://conductscience.org/library/papers/41335181PubMed
41312951In Silico and In Vitro Evaluation of Novel Small Molecule Inhibitors Targeting Apoptosis Pathways in Breast Cancer Cells.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/41312951PubMed
41183148Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development.Drug Dev Res2025https://conductscience.org/library/papers/41183148PubMed
41009411Quercetin and Its Structural Analogs as NUDT5 Inhibitors: A Preliminary In Silico Study.Int J Mol Sci2025https://conductscience.org/library/papers/41009411PubMed
41006418Identification of novel small molecule inhibitors targeting multiple methyltransferase like proteins against hepatocellular carcinoma.Sci Rep2025https://conductscience.org/library/papers/41006418PubMed
40849528Porphyrinic MOF-derived novel nanocomposite for gastric anticancer and Helicobacter pylori photoantibacterial effect assay.Sci Rep2025https://conductscience.org/library/papers/40849528PubMed
40678483Advances and challenges in drug design against dental caries: Application of in silico approaches.J Pharm Anal2025https://conductscience.org/library/papers/40678483PubMed

See all 103 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ALOX5240PubTator's text mininghttps://conductscience.org/library/genes/240NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
FLT42324PubTator's text mininghttps://conductscience.org/library/genes/2324NCBI Gene
GPER12852PubTator's text mininghttps://conductscience.org/library/genes/2852NCBI Gene
GTF2H5404672PubTator's text mininghttps://conductscience.org/library/genes/404672NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HSP90AA13320PubTator's text mininghttps://conductscience.org/library/genes/3320NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
MAP2K15604PubTator's text mininghttps://conductscience.org/library/genes/5604NCBI Gene
MAP2K25605PubTator's text mininghttps://conductscience.org/library/genes/5605NCBI Gene
MET4233PubTator's text mininghttps://conductscience.org/library/genes/4233NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32508653

GET https://conductscience.org/api/papers/v1/32508653/references?page=2